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The ﬁrst syntheses of the polyhydroxylated alkaloids (iminosugars) broussonetines D and M,
glycosidase inhibitors of the pyrrolidine class, have been performed in a convergent, stereocontrolled
way from D-serine as the chiral starting material. A cross metathesis step was one key feature of the
synthesis. The versatility of the synthetic concept chosen permits the access to many members of this
compound family, both natural ones and analogues thereof.
Introduction
Pyrrolidine alkaloids havebeen isolated fromspecies ofmanyplant
families,1 aswell as from some animal organisms.2 Members of this
compound class are known to exhibit a broad range of biological
activities.1d,3 Those bearing several hydroxyl functions display a
structural similarity to monosaccharides and are thus included
into the general group of the iminosugars.4 These compounds
display various types of heterocyclic systems (Fig. 1) and often
exhibit inhibitory activity on diverse glycosidases.5 This property,
which relies on structural similarities with sugars, is frequently
associated with valuable pharmacological utility.6 This therefore
has led to a signiﬁcant synthetic effort on members of this
compound class.7
Fig. 1 Structures of some representative iminosugars with inhibitory
ability on glycosidases.
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Within the pyrrolidine class of iminosugars, the broussonetines
constitute a particular subgroup with about 30 representatives.
They all have been isolated in recent years from the plant
species Broussonetia kazinoki Siebold (Moraceae), a deciduous
tree growing in several Far East countries, mainly China and
Japan, where it is used in folk medicine.8,9
Most broussonetines have been found to display marked
inhibitory activities on various glycosidases (IC50 values in the
micromolar to nanomolar range). Furthermore, their selectivity
has proven to be different from that of other standard iminosugars
such as deoxynojirimycin (DNJ). Broussonetine D, for instance,
was found to display a strong inhibitory activity (IC50, 29 nmol)
against bovine liver b-galactosidase, an enzyme not inhibited by
DNJ.8
The majority of the reported broussonetines show the general
structure depicted in Fig. 2. A common, polyhydroxylated pyrro-
lidine core is bound to a variable 13-carbon chain that displays
various types and degrees of functionalization. Fig. 2 shows ﬁve
selected examples.
Synthetic activity in the ﬁeld of the broussonetines has been
very scarce until now. The ﬁrst total synthesis of a member of
the broussonetine group in enantiopure form was carried out in
1999 by Yoda and coworkers,10a who prepared broussonetine C
(1) from D-tartaric acid as the chiral starting material. Four years
later, a second total synthesis of 1 was reported by Perlmutter
and coworkers, once again with a member of chiral pool,
D-arabinose, as the starting material.10b The third and to date last
total synthesis has been reported by Trost and coworkers, who
synthesized broussonetine G (3) by means of a palladium-based,
asymmetric catalytic procedure.10c
In the present communication, we report on the ﬁrst total
syntheses of broussonetines D (2) and M (4). The fact that
the broussonetines depicted above show a common pyrrolidine
core and a variable side chain led us to conceive the general
retrosynthetic analysis depicted in Scheme 1. Thus, the oleﬁnic
bond of a side chain as in 5 may be hydrogenated to the saturated
side chains of the type present in 2 or 4 and, at the same time,
allows for a cleavage via retro-cross-metathesis (retro-CRM) to a
common building block and a variable side chain fragment. The
common building block was then retrosynthetically cleaved in a
waywhich relied on that used in our recent synthesis of radicamine
B,11 and led to the commercially available amino acid D-serine as


























































Fig. 2 General structure of most broussonetines and some speciﬁc
examples.
Scheme 1 Retrosynthetic analysis of broussonetines D and M (PG =
protecting groups).
the chiral starting material. This retrosynthetic concept permits
an access not only to most of the natural broussonetines but also
to non-natural analogues thereof.
Results and discussion
The known Weinreb amide 6 was ﬁrst prepared from D-serine as
previously reported.11 Reaction of 6 with 3-butenyl-magnesium
bromide afforded in excellent yield ketone 7, which was then
stereoselectively reduced with L-selectride to secondary alcohol
8 (Scheme 2).12 Mesylation of 8 and acid treatment of mesylate
9 provided pyrrolidine 10 in a one-pot transformation which en-
compasses three consecutive steps: successive cleavage of the Boc
and acetonide groups, followed by intramolecular nucleophilic
substitution with formation of the C–N bond. Compound 10 was
then converted into oxazolidinone 11 for reasons to be explained
below.
Scheme 2 Synthesis of the pyrrolidine core (10/11).
The side chain fragments were prepared via standard methods
as shown in Scheme 3. Thus, Weinreb amide 12, prepared as
reported from d-valerolactone,13 was silylated to 13 and then
allowed to react with 5-hexenyllithium, obtained in turn via
halogen-lithium exchange in the corresponding bromide. This gave
ketone 14, suitable for crossmetathesiswith the pyrrolidinemoiety.
As for the side chain fragment of broussonetine M, Brown’s
asymmetric allylation14 of the known aldehyde 1515 furnished
homoallyl alcohol 16 in 92% optical purity and 76% overall yield
from the alcohol precursor of 15. Hydroboration-oxidation of
the oleﬁnic bond, benzylation of the two hydroxyl groups and
desilylation provided primary alcohol 19, which was then oxidized
to aldehyde 20. Wittig oleﬁnation of the latter afforded terminal
alkene 21. With the two necessary oleﬁns 14 and 21 now in
hand, we investigated their CRM reactions16 with pyrrolidine 10
(Scheme 4).
All attempts at CRMof 10with oleﬁn 14 in the presence of 10%
Grubbs’ second-generation catalyst 2217 andone equivalent of acid
(p-toluenesulfonic acid, triﬂuoroacetic acid or titanium tetraiso-
propoxide) in reﬂuxing CH2Cl2 gave disappointing results.18 As-
suming that this was due to the presence of residual, unprotonated
amine, we replaced 10 by its N,O-protected derivative 11. When
a 1 : 2 mixture of 11 and 14 was heated at reﬂux in CH2Cl2 for
24 h in the presence of 22,19 the desired CRM product 23 was
obtained as an inseparable 4 : 1 E/Z mixture in 63% yield. The


























































Scheme 3 Synthesis of the side chain fragments 14 and 21.
remaining products identiﬁed were the homodimers 24 and 25,
likewise formed as E/Z mixtures.20
We then discovered that the reaction could be better carried
out under microwave (MW) irradiation.21 In fact, while yields and
products remained essentially unchanged (62% of 23), the reaction
time was much shorter (1 h). Compound 23 was then subjected
to alkaline hydrolytic conditions, which caused cleavage of both
the oxazolidinone and TBDPS groups.22 The crude E/Z mixture
was stirred under a H2 atmosphere in an acidic medium to yield
broussonetine D (2) in good yield.23
A similar reaction sequence led to broussonetine M (4). CRM
of a 1 : 2 mixture of 11 and alkene 21 (Scheme 4) gave the coupling
product 27 as a 4 : 1 E/Z mixture in 60% yield, together with the
expected homodimers.Without separation of geometrical isomers,
27 was subjected to the same alkaline hydrolysis conditions
as above, followed by catalytic hydrogenation/hydrogenolysis in
acidic medium. This caused saturation of the oleﬁnic bond and
cleavage of the four benzyl groups to yield 4.
Experimental
General
NMRspectrawere recorded at 500MHz (1HNMR) and 125MHz
(13C NMR) in CDCl3 solution at 25 ◦C, if not otherwise indicated,
with the solvent signals as internal reference. The spectra of com-
poundswithN-Boc residuesweremeasured at higher temperatures
in order to have sharper signals. 13C NMR signal multiplicities
were determined with the DEPT pulse sequence. Mass spectra
were run in the EI (70 eV) or the FAB (m-nitrobenzyl alcohol
matrix) mode. IR data were measured as ﬁlms on NaCl plates
(oils) or as KBr pellets (solids), and are given only when relevant
functions (C=O,OH) are present. Optical rotations weremeasured
at 25 ◦C. Reactions which required an inert atmosphere were
carried out under dry N2 with ﬂame-dried glassware. Commercial
reagentswere used as received.THFandEt2Owere freshly distilled
from sodium-benzophenone ketyl. Dichloromethane was freshly
distilled from CaH2. Toluene was freshly distilled from sodium
wire. Tertiary amines were freshly distilled from KOH. Where
organic solutions were ﬁltered through a Celite pad, the pad was
additionally washed with the same solvent used, and the washings
Scheme 4 Final steps of the synthesis of broussonetines D (2) and M (4).


























































incorporated to the main organic layer. The latter was dried over
anhydrous Na2SO4 and the solvent was eliminated under reduced
pressure. Column chromatography was performed on a silica





Procedure A): Compounds 11 (197 mg, 0.5 mmol), 14 (422 mg,
1 mmol) and Grubbs’ catalyst 22 (42 mg, 0.05 mmol) were
dissolved in dry, deoxygenated CH2Cl2 (8 mL). The mixture was
heated at reﬂux under N2 for 24 h. Solvent removal under reduced
pressure gave a residue which was dissolved in Et2O (25 mL).
The organic layer was washed three times with water and then
dried on Na2SO4. After this, charcoal (1 g) was added and the
suspension stirred for 24 h at room temperature. Solvent removal
under reduced pressure and column chromatography on silica gel
(elution with hexanes-EtOAc, 8 : 2) yielded compound 23 (248mg,
63% as a 4 : 1 E/Z mixture). In addition, homodimers 24 (57 mg,
30% based on 11) and 25 (269 mg, 66% based on 14) were isolated,
likewise as ~ 4 : 1 E/Z mixtures. Procedure B): Compounds 11
(197 mg, 0.5 mmol), 14 (422 mg, 1 mmol) and Grubbs’ catalyst 22
(42 mg, 0.05 mmol) were dissolved in dry, deoxygenated CH2Cl2
(8 mL). The reaction mixture was placed in a CEM Discover
microwave oven and heated for 1 h at 100 ◦C (100 W power).
Work-up as above gave 23 (240 mg, 62%) together with 24 and 25
in yields similar to those of procedure A). Homodimer 25 could be
recycled to 23 through reaction with 11 under the same metathesis
conditions. It gave compound 23 in 57% yield, together with excess
25 and homodimer 24.Title compound (E +Zmixture): colourless
oil; IR nmax 1760, 1712 (C=O) cm-1; 1H NMR (signals from the
major E isomer) d 7.70 (4H, br d, J ~ 7.5 Hz), 7.45–7.25 (16H, br
m), 5.50–5.45 (2H,m), 4.61 (2H, br d, J = 11.6Hz), 4.50–4.40 (3H,
m), 4.10 (1H, dd, J = 9, 4 Hz), 4.05 (1H, m), 4.00–3.90 (2H, m),
3.87 (1H, m), 3.68 (2H, t, J = 6 Hz), 2.40–2.35 (4H, m), 2.20–2.10
(2H, m), 2.05–2.00 (2H, m), 1.70–1.60 (4H, m), 1.60–1.55 (4H, m),
1.38 (2H, br quint, J ~ 7.5 Hz), 1.07 (9H, s); 13C NMR (signals
from the major E isomer) d 211.1, 161.2, 137.3, 137.2, 134.0 (¥ 2),
19.2 (C), 135.5 (¥ 4), 131.1, 129.5 (¥ 2), 129.0, 128.6 (¥ 2), 128.5
(¥ 2), 128.2, 127.9, 127.7 (¥ 4), 127.6 (¥4), 88.8, 87.8, 62.8, 62.3
(CH), 72.7, 71.6, 67.2, 63.5, 42.5, 42.4, 32.3, 32.1, 32.0, 29.2, 29.1,
23.3, 20.3 (CH2), 26.9 (¥ 3) (CH3); HR FABMS m/z 788.4377




Obtained as described above as anE/Z mixture: colourless oil; 1H
NMR (signals from the major E isomer) d 7.45–7.20 (20H, br m),
5.50–5.40 (2H, m), 4.60 (4H, br d, J = 11.8 Hz), 4.50–4.40 (6H,
br m), 4.10–4.00 (4H, m), 3.95–3.80 (6H, br m), 2.20–2.00 (4H,
br m), 1.70–1.50 (4H, br m); 13C NMR (signals from the major E
isomer) d 161.2 (¥ 2), 137.5 (¥ 2), 137.3 (¥ 2) (C), 130.0 (¥ 2), 128.7
(¥ 5), 128.5 (¥ 5), 128.2 (¥ 2), 127.9 (¥ 2), 127.8 (¥ 6), 88.8 (¥ 2),
87.9 (¥ 2), 62.8 (¥ 2), 62.3 (¥ 2) (CH), 72.7 (¥ 2), 71.6 (¥ 2), 67.2
(¥ 2), 32.0 (¥ 2), 29.3 (¥ 2) (CH2).
1,20-Bis(tert-butyldiphenylsilyloxy)eicos-10E,Z-ene-5,16-dione
(25)
Obtained as described above as an E/Z mixture: colourless oil;
1H NMR (signals from the major E isomer) d 7.70 (8H, br d, J
~ 7.5 Hz), 7.45–7.25 (12H, br m), 5.40–5.35 (2H, m), 3.67 (4H, t,
J = 6.5 Hz), 2.37 (8H, br q, J ~ 7.5 Hz), 2.00 (4H, m), 1.65 (4H,
br quint, J ~ 7 Hz), 1.57 (8H, m), 1.35 (4H, br quint, J ~ 7 Hz),
1.06 (18H, s); 13C NMR (signals from the major E isomer) d 211.0
(¥ 2), 133.9 (¥ 4), 19.2 (¥ 2) (C), 135.5 (¥ 8), 130.2 (¥ 2), 129.5
(¥ 4), 127.6 (¥ 8) (CH), 63.5 (¥ 2), 42.5 (¥ 2), 42.4 (¥ 2), 37.3 (¥ 2),
32.0 (¥ 2), 29.2 (¥ 2), 23.3 (¥ 2), 20.3 (¥ 2) (CH2), 26.9 (¥ 6) (CH3).
13-[(2R,3R,4R,5R)-3,4-Bis(benzyloxy)-5-(hydroxymethyl)-
pyrrolidin-2-yl]-1-hydroxytridec-10E-en-5-one (26)
A solution of compound 23 (315 mg, 0.4 mmol) in EtOH–H2O
3 : 1 (10 mL) was treated with NaOH (400 mg, 10 mmol). The
reactionmixture was stirred at reﬂux for 8 h. After this, all volatiles
were removed under reduced pressure and the residue was taken
into brine, followed by extraction with EtOAc (3 ¥ 10 mL). The
organic layer was then dried on anhydrousNa2SO4 and evaporated
under reduced pressure. The residue was subjected to column
chromatography on silica gel (elution with CHCl3–MeOH, from
95 : 5 to 90 : 10) to furnish compound 26 (150 mg, 72%) as a
4 : 1 E/Z mixture. For the synthesis of broussonetine D, the E/Z
mixture was used as such in the hydrogenation step (see below).
Title compound (E + Z mixture): colourless oil; IR nmax 3390 (br,
OH), 1709 (C=O) cm-1; 1HNMR(signals from themajorE isomer)
d 7.40–7.30 (10H, br m), 5.40–5.30 (2H, m), 4.60–4.50 (4H, m),
3.85 (1H, m), 3.75–3.70 (1H, m), 3.65–3.55 (4H, br m), 3.45 (1H,
m), 3.25–3.20 (1H, m), 3.15 (3H, br s, NH, 2 OH), 2.43 (2H, t,
J = 7 Hz), 2.38 (2H, t, J = 7 Hz), 2.20–1.95 (4H, br m), 1.75–1.50
(8H, br m), 1.35 (2H, br quint, J ~ 7.5 Hz); 13C NMR (signals
from the major E isomer) d 211.2, 138.0, 137.9 (C), 131.0, 129.5,
129.0, 128.5 (¥ 2), 128.4 (¥ 2), 127.9 (¥ 2), 127.7 (¥ 3), 88.8, 85.5,
62.3, 61.6 (CH), 72.1 (¥ 2), 63.7, 61.5, 42.6, 42.3, 33.1, 32.2, 32.0,
29.5, 29.1, 23.3, 20.0 (CH2); HR FABMS m/z 524.3390 (M + H+),




The metathesis reaction was carried out with compounds 11
(197 mg, 0.5 mmol), 21 (366 mg, 1 mmol) and Grubbs’ catalyst
22 (42 mg, 0.05 mmol) in dry, deoxygenated CH2Cl2 (8 mL) under
the same conditions as in the previous case. Work-up as above
afforded 27 (220mg, 60%, as a 4 : 1E/Zmixture), togetherwith the
expected homodimers.Title compound (E +Zmixture): colourless
oil; IR nmax 1760 (C=O) cm-1; 1H NMR (signals from the major
E isomer) d 7.45–7.30 (20H, br m), 5.55–5.45 (2H, m), 4.65–4.60
(2H, m), 4.55–4.40 (7H, br m), 4.12 (1H, dd, J = 9, 4 Hz), 4.08
(1H, m), 3.94 (2H, m), 3.88 (1H, dd, J = 5, 2.6 Hz), 3.52 (2H,
br t, J ~ 6.5 Hz), 3.45 (1H, br quint, J ~ 5.5 Hz), 2.20–2.10 (2H,
m), 2.10–2.00 (2H, m), 1.80–1.50 (8H, br m), 1.50–1.30 (6H, br
m); 13C NMR (signals from the major E isomer) d 161.2, 139.0,
138.6, 137.3, 137.2 (C), 131.5, 128.5 (¥ 2), 128.4 (¥ 2), 128.3 (¥ 2),
128.2 (¥ 2), 128.1, 127.9, 127.8 (¥ 2), 127.7 (¥ 3), 127.6 (¥ 2),
127.5 (¥ 2), 127.4, 127.3, 88.8, 87.7, 78.7, 62.7, 62.2 (CH), 72.7,


























































72.6, 71.5, 70.7, 70.5, 67.1, 33.7, 32.5, 32.2, 30.3, 29.5, 29.3, 29.2,
25.6, 25.2 (CH2); HR FABMS m/z 732.4249 (M + H+), calcd. for
C47H58NO6, 732.4264.
Broussonetine D (2)
Compound 26 (26 mg, 0.05 mmol) as an E/Z mixture (see
above) was dissolved in MeOH (5 mL) and treated with 6M HCl
(0.5 mL). After addition of 10% Degussa-type Pd/C catalyst (30
mg), the mixture was placed under a H2 atmosphere and stirred
for 16 h at room temperature. The mixture was then ﬁltered
through Celite (washing with MeOH). Removal of all volatiles
under reduced pressure gave a residue which was dissolved in
MeOH (2 mL) and treated dropwise with 33% aq ammonia until
basic pH. Removal of all volatiles under reduced pressure gave
a residue which was chromatographed on silica gel (elution with
CHCl3:MeOH:NH4OH, from 95 : 4 : 1 to 70 : 29 : 1). The eluted
material was subsequently puriﬁed in a ion-exchange column
(Dowex 5Wx4-400 Aldrich, acidiﬁed with 0.5M HCl). Elution
was performed ﬁrst with distilled water (50 mL) and then with
1M aq ammonia (until elution of the product). This provided
broussonetineD (16mg, 94%).The identity of the synthetic sample
was conﬁrmed by direct comparison with an authentic sample
by means of co-chromatography in an HPLC-MS system. Title
compound: amorphous solid; [a]D +23.6 (c 0.4; MeOH), lit.24 [a]D
+22.9 (c 0.31; MeOH); IR nmax 3330 (br, OH), 1706 (C=O) cm-1;
1H NMR (pyridine-d5) d 4.70 (1H, t, J = 6.5 Hz), 4.41 (1H, t, J =
6.5 Hz), 4.25 (1H, dd, J = 11.2. 4.5 Hz), 4.20 (1H, dd, J = 11.2.
5.5 Hz), 3.86 (2H, t, J = 6.5 Hz), 3.82 (1H, m), 3.53 (1H, m), 2.48
(2H, t, J = 7.5 Hz), 2.36 (2H, t, J = 7.5 Hz), 2.05–2.00 (2H, m),
1.90–1.85 (2H, m), 1.80–1.70 (4H, br m), 1.65–1.50 (4H, br m),
1.40–1.15 (11H, br m); 13C NMR (pyridine-d5) d 210.5 (C), 84.2,
80.2, 65.2, 63.1 (CH), 63.4, 61.8, 42.7, 42.6, 35.2, 33.2, 30.2, 29.8
(several overlapped signals), 27.3, 24.2, 21.0 (CH2); HR FABMS
m/z 346.2585 (M + H+), calcd. for C18H36NO5, 346.2593.
There are some differences in the chemical shifts of some signals
between the synthetic and the natural sample,24 even though their
identity has been secured as described above. Most likely, these
differences are due to the presence of minute amounts of acid
and/or metal impurities, which markedly affect the position of
some signals, as already reported for basic nitrogen-containing
natural products.25
Broussonetine M (4)
Alkaline hydrolysis of the protecting oxazolidinone group in 27
was performed in the same manner as for compound 23 (see
above). A solution of compound 27 (183mg, 0.25mmol) in EtOH–
H2O 3 : 1 (7 mL) was treated with NaOH (280 mg, 7 mmol). The
reactionmixture was stirred at reﬂux for 8 h.Work-up and column
chromatography as for 23 → 26 gave a pyrrolidine derivative (as
an E/Z mixture) which was used as such in the next reaction. The
pyrrolidine derivative was then dissolved in MeOH (15 mL) and
treated with 6M HCl (1.5 mL). After addition of 10% Degussa-
type Pd/C catalyst (75 mg), the mixture was placed under a H2
atmosphere (1 atm) and stirred for 16 h at room temperature The
mixture was then ﬁltered through Celite (washing with MeOH).
Removal of all volatiles under reduced pressure gave a residue
which was dissolved in MeOH (3 mL) and treated dropwise with
33% aq ammonia until basic pH. Removal of all volatiles under
reduced pressure gave a residue which was chromatographed on
silica gel (elution with CHCl3:MeOH:NH4OH, from 95 : 4 : 1 to
70 : 29 : 1). The elutedmaterial was subsequently puriﬁed in an ion-
exchange column (Dowex 5Wx4–400 Aldrich, acidiﬁed with 0.5M
HCl). Elution was performed ﬁrst with distilled water (50 mL)
and then with 1M aq ammonia (until elution of the product).
This provided broussonetine M (61 mg, 70% overall from 27).
Title compound: amorphous solid; [a]D +6 (c 0.45; MeOH), lit.26
[a]D +5.9 (c 0.3; MeOH); IR nmax 3330 (br, OH) cm-1; 1H NMR
(pyridine-d5) d 4.90 (1H, t, J = 7 Hz), 4.65 (1H, t, J = 7 Hz), 4.45
dd (1H, dd, J = 11.5. 5.5 Hz), 4.41 dd (1H, dd, J = 11.5. 5 Hz),
4.26 (1H, m), 4.05 (1H, br q, J = 7.5 Hz), 3.96 (2H, t, J = 6.5 Hz),
3.90 (1H, m), 2.30–2.25 (2H, br m), 2.15–2.10 (1H, m), 2.05–2.00
(1H, m), 1.90–1.50 (8H, br m), 1.40–1.15 (16H, br m); 13C NMR
(pyridine-d5) d 80.7, 76.7, 70.9, 65.2, 63.0 (CH), 62.4, 59.7, 38.5,
35.2, 31.9, 30.3, 29.9, 29.8, 29.6, 29.5, 29.4, 26.7, 26.3 (CH2); HR
FABMS m/z 348.2763 (M + H+), calcd. for C18H38NO5, 348.2750.
As in the case of 2 and, in all likelihood, for the same reasons,
there are also differences in the chemical shifts of several signals
between the synthetic and the natural sample.25,26
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